OXIS International, Inc. engages in the research, development, and marketing of nutraceutical and cosmeceutical products in the field of oxidative stress reduction and inflammation. The company primarily develops a line of dietary supplements containing L-Ergothioneine (ERGO). ERGO is naturally occurring, water soluble, and amino acid antioxidant produced by microbes in the soil and found in various species of mushrooms and grapes, meats, and dairy products. It offers Ergo-Plex, a dietary supplement for the maintenance of joint health. The company also holds patents and patent applications for the protection of ERGO on mitochondria, the ERGO manufacturing process, and the neuroprotectant methods and compositions of ERGO. OXIS International, Inc. was founded in 1965 and is based in Beverly Hills, California.
Chairman, Chief Exec. Officer, Pres, Acting Principal Financial Officer, Acting Principal Accounting Officer, Chairman of Compensation Committee and Chairman of Axonyx Inc
Randall Moeckli
-
Sr. Director of Sales & Marketing
S. Colin Neill
65
Sec., Director, Chairman of Audit Committee and Member of Nominating Committee
Yesterday, OXIS International, Inc. (OTC:OXIS) hit a tremendous loss on the market. All of a sudden, the stock lost 17% of its price, while its traded volume exceeded 1 million shares for the day.read more
Yesterday the share price of OXIS International, Inc. (OTC:OXIS) stock tanked further on the strongest sale off for the past three years. It looks like OXIS had something to lose after it gapped up at the end of last week on the expectation of the company filing its annual report for the past year.read more
Yesterday, another press release made OXIS International, Inc. (OTC:OXIS) gap up. Still no stock promoters have presented themselves to the public, and as the volume was even smaller than the average for the highly illiquid stock, it looks like it was solely the news that attracted the buyers.read more
OXIS International, Inc. (OTC:OXIS) moved down again on the market. After soaring 8% on Tuesday, yesterday it lost 0.67% from its price and the up move was broken again.read more
Accounts payable
Short current long term debt
Other current liabilities
Cash and cash equivalents
Intangible assets
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
Still around the 10 cents, yet to see whether a reverse and positive trend could be sustained for Oxis International Inc.(OTC:OXIS) stock.read more
Yesterday, OXIS International, Inc. (OTC:OXIS) hit a tremendous loss on the market. All of a sudden, the stock lost 17% of its price, while its traded volume exceeded 1 million shares for the day.read more
Yesterday the share price of OXIS International, Inc. (OTC:OXIS) stock tanked further on the strongest sale off for the past three years. It looks like OXIS had something to lose after it gapped up at the end of last week on the expectation of the company filing its annual report for the past year.read more
Yesterday, another press release made OXIS International, Inc. (OTC:OXIS) gap up. Still no stock promoters have presented themselves to the public, and as the volume was even smaller than the average for the highly illiquid stock, it looks like it was solely the news that attracted the buyers.read more
OXIS International, Inc. (OTC:OXIS) moved down again on the market. After soaring 8% on Tuesday, yesterday it lost 0.67% from its price and the up move was broken again.read more
